Showing results (981-990 of 1,143) with videos related to
Sort By:
Pageof 115
Future Oncology (London, England)|March 4, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumorsAlison M Schram, John J Park, Antoine Italiano, et al.Diabetes & Metabolism|February 15, 2020
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht StudyN M J Hanssen, J L J M Scheijen, A J H M Houben, et al.Journal of the American Heart Association|July 26, 2021
Sleep Apnea is Associated With Accelerated Vascular Aging: Results From 2 European Community-Based Cohort StudiesQuentin Lisan, Thomas van Sloten, Pierre Boutouyrie, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 30, 2018
Cross-Sectional Associations Between Cardiac Biomarkers, Cognitive Performance, and Structural Brain Changes Are Modified by AgeMarja G J Veugen, Ronald M A Henry, Hans-Peter Brunner-La Rocca, et al.Frontiers in Physiology|May 11, 2017
Sedentary Behavior Is Only Marginally Associated with Physical Function in Adults Aged 40-75 Years-the Maastricht StudyJeroen H P M van der Velde, Hans H C M Savelberg, Julianne D van der Berg, et al.Frontiers in Endocrinology|March 7, 2022
Prevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht StudyVeerle van Hulten, Cindy Sarodnik, Johanna H M Driessen, et al.JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic TrialAlison M Schram, Nicoletta Colombo, Edward Arrowsmith, et al.Diabetes Care|September 30, 2021
Association of Type 2 Diabetes, According to the Number of Risk Factors Within Target Range, With Structural Brain Abnormalities, Cognitive Performance, and Risk of DementiaApril C E van Gennip, Coen D A Stehouwer, Martin P J van Boxtel, et al.British Journal of Cancer|September 4, 2021
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer typesChristian Rolfo, Alexander Drilon, David Hong, et al.Veterinary Immunology and Immunopathology|June 25, 1998
Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995D P Lunn, M A Holmes, D F Antczak, et al.Pageof 115